Jim Kovach

Advisor at Neuvivo - , ,

Jim Kovach's Colleagues at Neuvivo
Jennifer Larson

Head Of Communications - ALS Therapeutic Development

Contact Jennifer Larson

Ari Azhir

Chief Executive Officer

Contact Ari Azhir

Gregg Fergus

Board Of Directors, Head of Strategy and Business Development

Contact Gregg Fergus

Bruce Kaufman

Chief Financial Officer

Contact Bruce Kaufman

Jim Kovach's Contact Details
HQ
Location
Sacramento,California,United States
Company
Neuvivo
Jim Kovach's Company Details
Neuvivo logo, Neuvivo contact details

Neuvivo

, , • 7 Employees
Research

Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We have developed a patented macrophage-targeted technology, NP001, that addresses chronic inflammation, a key factor in the progressive loss of motor function in ALS.NP001 has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unmet medical need. We are working to move this compound toward approval and delivering an effective and safe new treatment for ALS.

Details about Neuvivo
Frequently Asked Questions about Jim Kovach
Jim Kovach currently works for Neuvivo.
Jim Kovach's role at Neuvivo is Advisor.
Jim Kovach's email address is ***@neuvivo.com. To view Jim Kovach's full email address, please signup to ConnectPlex.
Jim Kovach works in the Research industry.
Jim Kovach's colleagues at Neuvivo are Jennifer Larson, Ari Azhir, Gregg Fergus, Yuval Luria, Bruce Kaufman and others.
Jim Kovach's phone number is
See more information about Jim Kovach